跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5 条关于
“atebimetinib”
全部
5
临床试验
1
药物
0
机构
0
资讯
4
3个月前
Immuneering Doses First Patient in Phase III MAPKeeper 301 Trial of Atebimetinib Plus Modified Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Cancer
9个月前
Immuneering Receives FDA and EMA Alignment for Phase 3 Atebimetinib Trial in First-Line Pancreatic Cancer
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
3个月前
Immuneering Appoints Former Terns CFO Andrew Gengos as Chief Financial Officer Amid Pivotal Phase 3 Pancreatic Cancer Program